Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonalcoholic Steatohepatitis (NASH)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01874249
What this trial is testing

Non Invasive Assessment of Liver Fibrosis in Fatty Liver Disease

Who this might be right for
Non Alcoholic Fatty Liver Disease
Fundación Clínica Médica Sur 1,200
Not applicableStudy completedNCT03696797
What this trial is testing

Iron Reduction for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease

Who this might be right for
IronDiabetesNonalcoholic Fatty Liver
Wake Forest University Health Sciences 132
Early research (Phase 1)Study completedNCT03783897
What this trial is testing

A Drug-drug Interaction Study to Investigate the Effect of Coadministration of EDP-305 on the PK of a Combined Oral Contraceptive in Healthy Female Subjects

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Enanta Pharmaceuticals, Inc 43
Testing effectiveness (Phase 2)Ended earlyNCT04583423
What this trial is testing

MK-3655 in Individuals With Pre-cirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-3655-001)

Who this might be right for
Nonalcoholic Steatohepatitis
Merck Sharp & Dohme LLC 183
Not applicableStudy completedNCT01371396
What this trial is testing

Effect of Dietary Macronutrient Composition

Who this might be right for
Metabolic SyndromeNon-alcoholic Fatty Liver DiseaseObesity
University of Texas Southwestern Medical Center 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06160271
What this trial is testing

Study of Liver Fibrosis Stage Assessment by Fibroblast Activation Protein Imaging in Patients With Biopsy for Suspected or Proven Nonalcoholic Steatohepatitis

Who this might be right for
Non-alcoholic Steatohepatitis
Central Hospital, Nancy, France 72
Testing effectiveness (Phase 2)Looking for participantsNCT07193927
What this trial is testing

Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Mechanistic Trial

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseFatty Liver Disease, NonalcoholicOverweight (BMI > 25)
AB Biotics, SA 60
Early research (Phase 1)Looking for participantsNCT07214870
What this trial is testing

A Research Study of a Potential New Medicine (NNC4005-0001) for Liver Disease in Adult Participants With Increased Body Weight and Liver Fat

Who this might be right for
Fatty Liver Disease
Novo Nordisk A/S 60
Not applicableStudy completedNCT07768956
What this trial is testing

Effects of Turkish Coffee and Green Tea in Fatty Liver Disease

Who this might be right for
Non Alcoholic Fatty Liver Disease
Okan University 47
Not applicableStudy completedNCT00280527
What this trial is testing

Protocol for the Assessment of Variability in Histology and Gene Expression in Bariatric Surgery Patients.

Who this might be right for
Obesity
Northwestern University 43
Not applicableUnknownNCT06130202
What this trial is testing

Echocardiographic Findings as Markers of Subclinical Cardiac Dysfunction in Patients With Non-Alcoholic Fatty Liver Disease

Who this might be right for
NAFLD
Assiut University 165
Not applicableLooking for participantsNCT05528471
What this trial is testing

Fructose and Liver Diseases in Youth: Help Them FLY

Who this might be right for
Non-alcoholic Fatty Liver Disease
University of Alberta 70
Not applicableStudy completedNCT06097039
What this trial is testing

Fetuin-A, a Promising Serum Biomarker for Diagnosis of Non-Alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Zagazig University 100
Not applicableStudy completedNCT06629857
What this trial is testing

A Cross Sectional Study Evaluating the Mean Levels of Alpha Fetoprotein in Patients of Hepatocellular Carcinoma and Its Correlates in Pakistan

Who this might be right for
Carcinoma, Hepatocellular
Darul Sehat Hospital 94
Early research (Phase 1)Study completedNCT05712265
What this trial is testing

Study to Evaluate the Effects of a Cytochrome P450 2C19 Inhibitor on the Pharmacokinetics of Miricorilant

Who this might be right for
Antipsychotic Induced Weight GainNon-alcoholic Steatohepatitis (NASH)
Corcept Therapeutics 26
Not applicableLooking for participantsNCT03472157
What this trial is testing

Controlled Study Evaluating Bariatric Surgery as a Treatment for Severe NASH With Advanced Liver Fibrosis in Non-severe Obese Patients

Who this might be right for
SurgeryObesityNASH - Nonalcoholic Steatohepatitis+1 more
University Hospital, Lille 100
Not applicableNot Yet RecruitingNCT07827430
What this trial is testing

Impact of Overt and Subclinical Hypothyroidism on Liver Fibrosis in Patients With MASLD

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseNon-Alcoholic Fatty Liver DiseaseHypothyroidism+1 more
Assiut University 120
Not applicableLooking for participantsNCT06445361
What this trial is testing

Prevalence of NAFLD in T1DM Patients

Who this might be right for
NAFLDType 1 DiabetesFatty Liver, Nonalcoholic
Ziekenhuis Oost-Limburg 138
Not applicableLooking for participantsNCT07662356
What this trial is testing

Clinical Course and Biomarkers Associated With Nonalcoholic Fatty Liver Disease (NAFLD) in Chinese Patients With Obesity

Who this might be right for
Nonalcoholic Fatty Liver Disease (NAFLD)
Chinese University of Hong Kong 200
Large-scale testing (Phase 3)WithdrawnNCT02541045
What this trial is testing

Clinical Trial to Evaluate the Efficacy of Metadoxine as a Therapy for Patients With Non-alcoholic Steatohepatitis

Who this might be right for
Non-alcoholic Steatohepatitis
Hospital General de Mexico
Next Page